Apolipoprotein C-III: The Small Protein With Sizeable Vascular Risk

Affiliations

¹ From the Department of Cardiovascular Medicine, University of Maryland School of Medicine and Veterans Affairs Medical Center (VAMC), Baltimore. mmiller@som.umaryland.edu.

Editorial

Michael Miller. Arterioscler Thromb Vasc Biol. 2017 Jun.

. 2017 Jun;37(6):1013-1014.

doi: 10.1161/ATVBAHA.117.309493.

¹ From the Department of Cardiovascular Medicine, University of Maryland School of Medicine and Veterans Affairs Medical Center (VAMC), Baltimore. mmiller@som.umaryland.edu.

No abstract available

Keywords: Editorials; apolipoprotein C-III; coronary artery disease; hypertriglyceridemia; lipoprotein lipase; lipoproteins, VLDL.

Comment on

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
van Capelleveen JC, Bernelot Moens SJ, Yang X, Kastelein JJP, Wareham NJ, Zwinderman AH, Stroes ESG, Witztum JL, Hovingh GK, Khaw KT, Boekholdt SM, Tsimikas S. van Capelleveen JC, et al. Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1206-1212. doi: 10.1161/ATVBAHA.117.309007. Epub 2017 May 4. Arterioscler Thromb Vasc Biol. 2017. PMID: 28473441 Free PMC article.